GSTT2B
gene geneOn this page
Also known as GSTT2P
Summary
GSTT2B (glutathione S-transferase theta 2B, HGNC:33437) is a protein-coding gene on chromosome 22q11.23, encoding Glutathione S-transferase theta-2B (P0CG30). Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.
The protein encoded by this gene, glutathione S-transferase (GST) theta 2B (GSTT2B), is a member of a superfamily of proteins that catalyze the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds. Human GSTs can be divided into five main classes: alpha, mu, pi, theta, and zeta. The theta class includes GSTT1, GSTT2, and GSTT2B. GSTT2 and GSTT2B are nearly identical to each other, and share 55% amino acid identity with GSTT1. All three genes may play a role in human carcinogenesis. The GSTT2B gene is a pseudogene in some populations.
Source: NCBI Gene 653689 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 8 total
- MANE Select transcript:
NM_001080843
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33437 |
| Approved symbol | GSTT2B |
| Name | glutathione S-transferase theta 2B |
| Location | 22q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | GSTT2P |
| Ensembl gene | ENSG00000133433 |
| Ensembl biotype | protein_coding |
| Entrez | 653689 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000290765, ENST00000404172, ENST00000895419, ENST00000932445, ENST00000964515
RefSeq mRNA: 2 — MANE Select: NM_001080843
NM_001080843, NM_001363804
CCDS: CCDS33617, CCDS87010
Canonical transcript exons
ENST00000290765 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001727999 | 23958285 | 23958458 |
| ENSE00001734445 | 23958551 | 23958701 |
| ENSE00001749600 | 23960294 | 23960381 |
| ENSE00001833725 | 23961020 | 23961195 |
| ENSE00001883656 | 23957414 | 23957932 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 96.33.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9431 / max 37.6472, expressed in 529 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 191349 | 0.9431 | 529 |
Top tissues by expression
137 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 96.33 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.58 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.03 | gold quality |
| adrenal tissue | UBERON:0018303 | 94.02 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.51 | gold quality |
| apex of heart | UBERON:0002098 | 92.85 | gold quality |
| adrenal gland | UBERON:0002369 | 92.02 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 91.80 | gold quality |
| fundus of stomach | UBERON:0001160 | 90.92 | gold quality |
| right lobe of liver | UBERON:0001114 | 90.43 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.60 | gold quality |
| stromal cell of endometrium | CL:0002255 | 89.57 | gold quality |
| prostate gland | UBERON:0002367 | 88.91 | gold quality |
| pituitary gland | UBERON:0000007 | 88.78 | gold quality |
| left coronary artery | UBERON:0001626 | 88.48 | gold quality |
| right frontal lobe | UBERON:0002810 | 88.26 | gold quality |
| right atrium auricular region | UBERON:0006631 | 88.12 | gold quality |
| right ovary | UBERON:0002118 | 88.06 | gold quality |
| left ovary | UBERON:0002119 | 87.87 | gold quality |
| hypothalamus | UBERON:0001898 | 87.86 | gold quality |
| body of stomach | UBERON:0001161 | 87.81 | gold quality |
| amygdala | UBERON:0001876 | 87.76 | gold quality |
| temporal lobe | UBERON:0001871 | 87.70 | gold quality |
| primary visual cortex | UBERON:0002436 | 87.67 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.63 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 87.60 | gold quality |
| body of pancreas | UBERON:0001150 | 87.54 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 87.38 | gold quality |
| ascending aorta | UBERON:0001496 | 87.25 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 87.21 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.12 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
32 targeting GSTT2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-4658 | 99.77 | 64.94 | 514 |
| HSA-MIR-6790-5P | 99.77 | 65.24 | 505 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-3659 | 99.70 | 67.97 | 694 |
| HSA-MIR-26A-1-3P | 99.64 | 66.81 | 788 |
| HSA-MIR-26A-2-3P | 99.64 | 66.82 | 786 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-4688 | 99.48 | 64.68 | 828 |
| HSA-MIR-6743-5P | 99.48 | 63.60 | 721 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-4652-3P | 99.33 | 70.02 | 2742 |
| HSA-MIR-194-5P | 99.01 | 69.65 | 1465 |
| HSA-MIR-520G-3P | 98.91 | 67.38 | 1914 |
| HSA-MIR-520H | 98.91 | 67.38 | 1914 |
| HSA-MIR-6804-3P | 98.72 | 64.82 | 852 |
| HSA-MIR-3135B | 98.61 | 65.33 | 1470 |
| HSA-MIR-6731-3P | 98.61 | 67.86 | 749 |
| HSA-MIR-6873-5P | 98.45 | 66.14 | 1417 |
| HSA-MIR-4778-5P | 97.96 | 68.06 | 1634 |
| HSA-MIR-10526-3P | 97.86 | 64.97 | 1342 |
| HSA-MIR-22-5P | 97.67 | 68.92 | 1355 |
| HSA-MIR-192-3P | 97.52 | 67.66 | 1001 |
| HSA-MIR-320E | 97.49 | 65.96 | 865 |
| HSA-MIR-3139 | 96.68 | 66.77 | 652 |
| HSA-MIR-28-5P | 96.16 | 66.12 | 579 |
Literature-anchored findings (GeneRIF, showing 4)
- study describes a previously uncharacterized 38-kilo-base (kb) long deletion polymorphism of GSTT2B located within a 61-kb DNA inverted repeat (PMID:19424424)
- results suggest that the presence of the recently described GSTT2B deletion may have a protective effect on the risk of OSCC in the Mixed Ancestry South African population (PMID:22216261)
- Results GSTT2B insertion allele was associated with an increased risk of being small for gestational age indicate that (PMID:22676722)
- The data highlights that GSTT2B copy number variant is not associated with the investigated complex diseases in Italian patients. (PMID:26207597)
Cross-species orthologs
42 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gstr | ENSDARG00000042620 |
| danio_rerio | gstt2 | ENSDARG00000095464 |
| mus_musculus | Gstt2 | ENSMUSG00000033318 |
| rattus_norvegicus | Gstt2 | ENSRNOG00000052415 |
| drosophila_melanogaster | GstD1 | FBGN0001149 |
| drosophila_melanogaster | GstD2 | FBGN0010038 |
| drosophila_melanogaster | GstD3 | FBGN0010039 |
| drosophila_melanogaster | GstD4 | FBGN0010040 |
| drosophila_melanogaster | GstD5 | FBGN0010041 |
| drosophila_melanogaster | GstD6 | FBGN0010042 |
| drosophila_melanogaster | GstD7 | FBGN0010043 |
| drosophila_melanogaster | GstD8 | FBGN0010044 |
| drosophila_melanogaster | GstE12 | FBGN0027590 |
| drosophila_melanogaster | Clic | FBGN0030529 |
| drosophila_melanogaster | GstT3 | FBGN0031117 |
| drosophila_melanogaster | GstE13 | FBGN0033381 |
| drosophila_melanogaster | GstE1 | FBGN0034335 |
| drosophila_melanogaster | GstE11 | FBGN0034354 |
| drosophila_melanogaster | GstO3 | FBGN0035904 |
| drosophila_melanogaster | GstO2 | FBGN0035906 |
| drosophila_melanogaster | GstO1 | FBGN0035907 |
| drosophila_melanogaster | GstD9 | FBGN0038020 |
| drosophila_melanogaster | GstD10 | FBGN0042206 |
| drosophila_melanogaster | GstT1 | FBGN0050000 |
| drosophila_melanogaster | GstT2 | FBGN0050005 |
| drosophila_melanogaster | GstE9 | FBGN0063491 |
| drosophila_melanogaster | GstE8 | FBGN0063492 |
| drosophila_melanogaster | GstE7 | FBGN0063493 |
| drosophila_melanogaster | GstE6 | FBGN0063494 |
| drosophila_melanogaster | GstE5 | FBGN0063495 |
| drosophila_melanogaster | GstE4 | FBGN0063496 |
| drosophila_melanogaster | GstE3 | FBGN0063497 |
| drosophila_melanogaster | GstE2 | FBGN0063498 |
| drosophila_melanogaster | GstE10 | FBGN0063499 |
| drosophila_melanogaster | se | FBGN0086348 |
| caenorhabditis_elegans | exc-4 | WBGENE00001365 |
| caenorhabditis_elegans | WBGENE00001371 | |
| caenorhabditis_elegans | gst-43 | WBGENE00001791 |
| caenorhabditis_elegans | WBGENE00001792 | |
| caenorhabditis_elegans | WBGENE00015337 | |
| caenorhabditis_elegans | WBGENE00021817 | |
| caenorhabditis_elegans | WBGENE00043097 |
Paralogs (14): GSTO2 (ENSG00000065621), GSTT2 (ENSG00000099984), GSTZ1 (ENSG00000100577), GDAP1 (ENSG00000104381), CLIC5 (ENSG00000112782), GDAP1L1 (ENSG00000124194), GSTO1 (ENSG00000148834), CLIC2 (ENSG00000155962), CLIC6 (ENSG00000159212), CLIC4 (ENSG00000169504), CLIC3 (ENSG00000169583), CLIC1 (ENSG00000213719), EEF1G (ENSG00000254772), GSTT4 (ENSG00000276950)
Protein
Protein identifiers
Glutathione S-transferase theta-2B — P0CG30 (reviewed: P0CG30)
Alternative names: Glutathione S-transferase theta-2
All UniProt accessions (3): P0CG30, G9J6Q5, Q6ICJ4
UniProt curated annotations — full annotation on UniProt →
Function. Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Has a sulfatase activity.
Subunit / interactions. Homodimer.
Subcellular location. Cytoplasm. Cytosol.
Tissue specificity. Expressed at low levels in liver. In lung, expressed at low levels in ciliated bronchiolar cells, alveolar macrophages and alveolar type II cells.
Similarity. Belongs to the GST superfamily. Theta family.
RefSeq proteins (2): NP_001074312, NP_001350733 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004045 | Glutathione_S-Trfase_N | Domain |
| IPR004046 | GST_C | Domain |
| IPR010987 | Glutathione-S-Trfase_C-like | Domain |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
| IPR036282 | Glutathione-S-Trfase_C_sf | Homologous_superfamily |
| IPR040075 | GST_N_Theta | Domain |
| IPR040077 | GST_C_Theta | Domain |
| IPR040079 | Glutathione_S-Trfase | Family |
| IPR051369 | GST_Theta | Family |
Pfam: PF00043, PF02798
Enzyme classification (BRENDA):
- EC 2.5.1.18 — glutathione transferase (BRENDA: 178 organisms, 548 substrates, 680 inhibitors, 878 Km, 525 kcat entries)
Substrate kinetics (BRENDA)
79 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| 1-CHLORO-2,4-DINITROBENZENE | 0.0003–223.6 | 289 |
| GLUTATHIONE | 0.0002–532.43 | 253 |
| GSH | 0.0003–37.4 | 62 |
| REDUCED GLUTATHIONE | 0.017–11.4 | 24 |
| ETHACRYNIC ACID | 0.0001–2.43 | 19 |
| CUMENE HYDROPEROXIDE | 0.038–14.3 | 10 |
| (+)-2-BROMO-3-(4-NITROPHENYL)PROPANOIC ACID | 0.023–0.417 | 8 |
| MONOCHLOROBIMANE | 0.004–0.25 | 8 |
| 4-CHLORO-7-NITROBENZO-2-OXA-1,3-DIAZOLE | 0.324–3.866 | 7 |
| 1-IODOHEXANE | 0.009–0.059 | 6 |
| ALACHLOR | 0.042–7.23 | 6 |
| PHENETHYL ISOTHIOCYANATE | 0.0065–0.14 | 6 |
| STYRENE 7,8-OXIDE | 0.064–0.365 | 6 |
| 1,2-DICHLORO-4-NITROBENZENE | 0.27–1.4 | 5 |
| 1-CHLORO-2,3-DINITROBENZOATE | 0.21–20.7 | 5 |
Catalyzed reactions (Rhea), 1 shown:
- RX + glutathione = an S-substituted glutathione + a halide anion + H(+) (RHEA:16437)
UniProt features (34 total): helix 13, strand 6, turn 4, binding site 4, sequence conflict 2, domain 2, initiator methionine 1, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4MPG | X-RAY DIFFRACTION | 1.95 |
| 1LJR | X-RAY DIFFRACTION | 3.2 |
| 2LJR | X-RAY DIFFRACTION | 3.2 |
| 3LJR | X-RAY DIFFRACTION | 3.3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CG30-F1 | 98.16 | 0.99 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 40–41; 53–54; 66–67; 104–107
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-156590 | Glutathione conjugation |
MSigDB gene sets: 25 (showing top):
REACTOME_BIOLOGICAL_OXIDATIONS, GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY, GOBP_AMIDE_METABOLIC_PROCESS, REACTOME_GLUTATHIONE_CONJUGATION, GOBP_GLUTATHIONE_METABOLIC_PROCESS, GOBP_MODIFIED_AMINO_ACID_METABOLIC_PROCESS, REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS, MIR4306, MIR6739_5P, MIR6733_5P, MIR3153, MIR4778_5P, MIR520G_3P_MIR520H, MIR6873_5P, MIR4688
GO Biological Process (1): glutathione metabolic process (GO:0006749)
GO Molecular Function (3): glutathione transferase activity (GO:0004364), protein binding (GO:0005515), transferase activity (GO:0016740)
GO Cellular Component (3): cytoplasm (GO:0005737), cytosol (GO:0005829), extracellular exosome (GO:0070062)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Phase II - Conjugation of compounds | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| modified amino acid metabolic process | 1 |
| sulfur compound metabolic process | 1 |
| transferase activity, transferring alkyl or aryl (other than methyl) groups | 1 |
| binding | 1 |
| catalytic activity | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
2103 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GSTT2B | HPGDS | O60760 | 888 |
| GSTT2B | GSTP1 | P09211 | 791 |
| GSTT2B | FBLN1 | P23142 | 772 |
| GSTT2B | GSTM1 | P09488 | 770 |
| GSTT2B | GSTK1 | Q9Y2Q3 | 747 |
| GSTT2B | GSTO2 | Q9H4Y5 | 741 |
| GSTT2B | GSTO1 | P78417 | 670 |
| GSTT2B | GSTM2 | P28161 | 669 |
| GSTT2B | GSTA4 | O15217 | 652 |
| GSTT2B | GSTM3 | P21266 | 649 |
| GSTT2B | GSTM4 | Q03013 | 643 |
| GSTT2B | SLCO6A1 | Q86UG4 | 643 |
| GSTT2B | GSTA1 | P08263 | 631 |
| GSTT2B | GSTZ1 | O43708 | 630 |
| GSTT2B | GSTM5 | P46439 | 622 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | GSTT2B | psi-mi:“MI:0915”(physical association) | 0.510 |
| GSTT2B | SIRT2 | psi-mi:“MI:0914”(association) | 0.350 |
| GSTT1 | ENSA | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (21): GSTP1 (Co-fractionation), GSTP1 (Co-fractionation), GSTT2 (Affinity Capture-MS), SPDL1 (Affinity Capture-MS), NMD3 (Affinity Capture-MS), CARD9 (Affinity Capture-MS), SIRT2 (Affinity Capture-MS), GSTT2B (Affinity Capture-MS), MOCS2 (Affinity Capture-MS), GSTT2 (Affinity Capture-MS), SPDL1 (Affinity Capture-MS), NMD3 (Affinity Capture-MS), CARD9 (Affinity Capture-MS), SIRT2 (Affinity Capture-MS), NFRKB (Co-fractionation)
ESM2 similar proteins: A0A1W2PR19, A6QQZ0, O09131, O65857, O76483, O88741, P09488, P0CG29, P0CG30, P21266, P28161, P28342, P30109, P30568, P30713, P42760, P46409, P46430, P46439, P46440, P48774, P57108, P78417, Q01579, Q03013, Q03425, Q03662, Q4V8E6, Q5BK56, Q5R8E8, Q61133, Q64471, Q84TK0, Q8R5I6, Q8TB36, Q9BEA9, Q9BEB0, Q9C6C8, Q9D4P7, Q9FE46
Diamond homologs: A0A1U8QXK4, A0A6J4B5J2, A2Q127, C8VQ63, P0CG29, P0CG30, P12261, P26641, P26642, P29547, P29694, P36008, P40921, P42936, Q00717, Q29387, Q3SZV3, Q4R7H5, Q4WB03, Q5Z627, Q68FR6, Q6PE25, Q6YW46, Q90YC0, Q9D8N0, Q9FUM1, Q9VG98, Q9ZRI7, S0EHD0, W7MMJ0, A0A1W2PR19, O76483, O77473, P20135, P30711, P30713, P46430, P57108, Q01579, Q03425
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1066 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:23957753:AG:A | donor_gain | 1.0000 |
| 22:23957929:CCGG:C | acceptor_gain | 1.0000 |
| 22:23957930:CGGC:C | acceptor_gain | 1.0000 |
| 22:23958454:AACAC:A | acceptor_gain | 1.0000 |
| 22:23958455:ACAC:A | acceptor_gain | 1.0000 |
| 22:23958456:CAC:C | acceptor_gain | 1.0000 |
| 22:23958456:CACC:C | acceptor_gain | 1.0000 |
| 22:23958457:ACC:A | acceptor_loss | 1.0000 |
| 22:23958458:CCT:C | acceptor_loss | 1.0000 |
| 22:23958459:C:CC | acceptor_gain | 1.0000 |
| 22:23958459:CTGAT:C | acceptor_loss | 1.0000 |
| 22:23958460:T:C | acceptor_loss | 1.0000 |
| 22:23958462:A:AC | acceptor_gain | 1.0000 |
| 22:23958547:TCAC:T | donor_loss | 1.0000 |
| 22:23958548:CACCT:C | donor_loss | 1.0000 |
| 22:23958697:CCGAG:C | acceptor_gain | 1.0000 |
| 22:23958698:CGAG:C | acceptor_gain | 1.0000 |
| 22:23958698:CGAGC:C | acceptor_gain | 1.0000 |
| 22:23958700:AG:A | acceptor_gain | 1.0000 |
| 22:23958700:AGCT:A | acceptor_loss | 1.0000 |
| 22:23958702:C:CA | acceptor_loss | 1.0000 |
| 22:23958702:C:CC | acceptor_gain | 1.0000 |
| 22:23958872:T:TA | donor_gain | 1.0000 |
| 22:23960318:T:A | donor_gain | 1.0000 |
| 22:23960377:CTGCC:C | acceptor_gain | 1.0000 |
| 22:23960378:TGCC:T | acceptor_gain | 1.0000 |
| 22:23960380:CC:C | acceptor_gain | 1.0000 |
| 22:23960381:CC:C | acceptor_gain | 1.0000 |
| 22:23960382:C:CC | acceptor_gain | 1.0000 |
| 22:23961015:CCCA:C | donor_loss | 1.0000 |
AlphaMissense
1574 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:23958342:G:C | F156L | 0.978 |
| 22:23958342:G:T | F156L | 0.978 |
| 22:23958344:A:G | F156L | 0.978 |
| 22:23961089:G:T | R15S | 0.969 |
| 22:23961090:G:C | S14R | 0.963 |
| 22:23961090:G:T | S14R | 0.963 |
| 22:23961092:T:G | S14R | 0.963 |
| 22:23958652:A:G | W84R | 0.961 |
| 22:23958652:A:T | W84R | 0.961 |
| 22:23958701:G:C | S67R | 0.961 |
| 22:23958701:G:T | S67R | 0.961 |
| 22:23960295:T:G | S67R | 0.961 |
| 22:23960359:G:C | F45L | 0.961 |
| 22:23960359:G:T | F45L | 0.961 |
| 22:23960361:A:G | F45L | 0.961 |
| 22:23958360:G:C | F150L | 0.959 |
| 22:23958360:G:T | F150L | 0.959 |
| 22:23958362:A:G | F150L | 0.959 |
| 22:23961088:C:G | R15P | 0.958 |
| 22:23957879:C:A | W193C | 0.948 |
| 22:23957879:C:G | W193C | 0.948 |
| 22:23957881:A:G | W193R | 0.945 |
| 22:23957881:A:T | W193R | 0.945 |
| 22:23961070:G:T | A21D | 0.945 |
| 22:23960303:A:G | L64S | 0.944 |
| 22:23958601:A:G | W101R | 0.943 |
| 22:23958601:A:T | W101R | 0.943 |
| 22:23958313:T:A | D166V | 0.940 |
| 22:23961055:A:G | I26T | 0.939 |
| 22:23960347:G:C | N49K | 0.938 |
dbSNP variants (sampled 300 via entrez): RS1003287663 (22:23958251 G>A), RS1003626883 (22:23957892 C>T), RS1006732496 (22:23959350 C>T), RS1007215800 (22:23959966 C>T), RS1007761328 (22:23957135 C>G), RS1017654543 (22:23958925 T>C), RS1021931656 (22:23958622 G>A,C), RS1026501187 (22:23957663 G>C,T), RS1027636699 (22:23959682 A>G), RS1027708348 (22:23960026 G>A), RS1029936962 (22:23958809 G>C), RS1033793744 (22:23958267 C>A), RS1037866466 (22:23957140 C>G,T), RS1037897466 (22:23958093 G>T), RS1039545819 (22:23959970 TCTC>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001277_19 | Liver enzyme levels (gamma-glutamyl transferase) | 2.000000e-09 |
| GCST90011898_167 | Alanine aminotransferase levels | 2.000000e-09 |
| GCST90011900_16 | Serum alkaline phosphatase levels | 8.000000e-17 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
| EFO:0004533 | alkaline phosphatase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | increases expression | 1 |
| Acetylglucosamine | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1TB | Abcam HeLa GSTT2B KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.